153 related articles for article (PubMed ID: 23878284)
1. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
Lim HK; Kim JK; Kim KA; Cho KS
Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
7. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.
Akin O; Sala E; Moskowitz CS; Kuroiwa K; Ishill NM; Pucar D; Scardino PT; Hricak H
Radiology; 2006 Jun; 239(3):784-92. PubMed ID: 16569788
[TBL] [Abstract][Full Text] [Related]
8. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.
Vargas HA; Akin O; Franiel T; Goldman DA; Udo K; Touijer KA; Reuter VE; Hricak H
Radiology; 2012 Mar; 262(3):894-902. PubMed ID: 22357889
[TBL] [Abstract][Full Text] [Related]
9. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
[TBL] [Abstract][Full Text] [Related]
10. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.
Vargas HA; Akin O; Shukla-Dave A; Zhang J; Zakian KL; Zheng J; Kanao K; Goldman DA; Moskowitz CS; Reuter VE; Eastham JA; Scardino PT; Hricak H
Radiology; 2012 Nov; 265(2):478-87. PubMed ID: 22952382
[TBL] [Abstract][Full Text] [Related]
12. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.
Weinreb JC; Blume JD; Coakley FV; Wheeler TM; Cormack JB; Sotto CK; Cho H; Kawashima A; Tempany-Afdhal CM; Macura KJ; Rosen M; Gerst SR; Kurhanewicz J
Radiology; 2009 Apr; 251(1):122-33. PubMed ID: 19332850
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
15. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?
Turkbey B; Shah VP; Pang Y; Bernardo M; Xu S; Kruecker J; Locklin J; Baccala AA; Rastinehad AR; Merino MJ; Shih JH; Wood BJ; Pinto PA; Choyke PL
Radiology; 2011 Feb; 258(2):488-95. PubMed ID: 21177390
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM
Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992
[TBL] [Abstract][Full Text] [Related]
17. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
18. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
Liu X; Zhou L; Peng W; Wang C; Wang H
Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
